
Raba Life Sciences Private Limited
Founded in 2020 and headquartered in Telangana, India.
Founded in 2020 and headquartered in Telangana, India.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U15134TG2020PTC145034
145034
Private Limited Indian Non-Government Company
20 Oct 2020
-
-
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkata Chalasani ![]() | Director | 20-Oct-2020 | Current |
Shailaja Golechha ![]() | Director | 20-Oct-2020 | Current |
Enhance accessibility to Raba Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Raba Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Shailaja Golechha is a mutual person
Shailaja Golechha and Venkata Chalasani are mutual person
Shailaja Golechha and Venkata Chalasani are mutual person
Shailaja Golechha and Venkata Chalasani are mutual person
Shailaja Golechha and Venkata Chalasani are mutual person
Shailaja Golechha and Venkata Chalasani are mutual person
There are no open charges registered against the company as per our records.
Raba Life Sciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Raba Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raba Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shailaja Golechha was appointed as a Director was appointed as a Director on 20 Oct 2020 & has been associated with this company since 4 years 6 months .
Venkata Narasimha Rao Chalasani was appointed as a Director was appointed as a Director on 20 Oct 2020 & has been associated with this company since 4 years 6 months .
Raba Life Sciences Private Limited was registered on 20 Oct 2020 with Roc Hyderabad & aged 4 years 6 months as per MCA records.
Raba Life Sciences Private Limited was incorporated on 20 Oct 2020.
The authorized share capital of Raba Life Sciences Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Raba Life Sciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Raba Life Sciences Private Limited is Plot No 2 Block Incf Area Phase 5 Ida, India, Cherlapally, Telangana, 500051.
The corporate identification number (CIN) of Raba Life Sciences Private Limited is U15134TG2020PTC145034 and the company number is 145034 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.